Dermatologic Therapy最新文献_第10页

The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study 中国Omicron大流行期间非住院COVID-19银屑病患者的COVID-19症状和皮肤表现特征：基于单中心调查的研究

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-12-26 DOI: 10.1155/2023/1559937

Yue Xiao, Xiwen Zhang, Xun Feng, Jingya Gao, Furong Li, Wenyao Mi, Mingqi Wang, Yuanxia Gu, Yiyi Wang, Wen Wang, Wei Li

{"title":"The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study","authors":"Yue Xiao, Xiwen Zhang, Xun Feng, Jingya Gao, Furong Li, Wenyao Mi, Mingqi Wang, Yuanxia Gu, Yiyi Wang, Wen Wang, Wei Li","doi":"10.1155/2023/1559937","DOIUrl":"10.1155/2023/1559937","url":null,"abstract":"<div>\u0000 Background. The global impact of coronavirus 2019 (COVID-19) has raised concerns about the management of psoriasis patients, especially among those using biologics. Methods. We conducted a survey-based research among Omicron-infected (confirmed, probable, and suspected ones) psoriasis patients in the department of dermatology, West China Hospital, Sichuan University, from January 9th to January 22nd, 2023. We collected demographic and clinical information (psoriasis- and COVID-19-related) and conducted statistics analysis. Results. Of the 240 patients enrolled, they were classified by the psoriatic treatment, as biologics (n = 138), nonbiological systematic treatment (n = 52), and topical treatment or without pharmacological treatment (n = 50). This study showed the characteristics of Omicron-related symptoms and cutaneous signs in patients. We observed that patients who received topical treatment or without pharmacological treatment had a lower risk of presenting with COVID-19 symptoms in the fully adjusted logistic model (OR = 0.40, 95% CI: 0.18–0.90, and P = 0.025). Moreover, in the model for skin manifestations, nonbiological systematic treatment (OR = 2.15, 95% CI: 1.08–4.27, and P = 0.029) and high BMI (OR = 1.10, 95% CI: 1.00–1.20, and P = 0.042) were correlative factors. Conclusions. Our data suggested that differential psoriatic treatment might be a correlative factor in developing symptomatic or asymptomatic Omicron infection and presenting cutaneous signs.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/1559937","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139157540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis 银屑病患者对 TNF-α 抑制剂的耐药性

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-12-21 DOI: 10.1155/2023/7399468

Amirmansoor Gholami, Ahmad Vafaeian, Maryam Daneshpazhooh, Ifa Etesami, Kamran Balighi, Delnavaz Jan, Ali Salehi Farid, Ali Vafaei, Hamidreza Mahmoudi

{"title":"Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis","authors":"Amirmansoor Gholami, Ahmad Vafaeian, Maryam Daneshpazhooh, Ifa Etesami, Kamran Balighi, Delnavaz Jan, Ali Salehi Farid, Ali Vafaei, Hamidreza Mahmoudi","doi":"10.1155/2023/7399468","DOIUrl":"10.1155/2023/7399468","url":null,"abstract":"<div>\u0000 Background. Treatment resistance to biologic treatment at specific sites in the body is a challenging issue. However, there is insufficient evidence for factors affecting the resistance of these areas to biological therapies. Methods. In this study, patients with moderate-to-severetreatment-resistant psoriasis who were biologic naïve and referred to Razi hospital were included. The relationship between treatment resistance in different areas and demographic and clinical variables was investigated. Results. A total of 131 biologic-naïve patients with psoriasis treated with anti-TNF-α were included in this study. The most common resistant sites included the scalp, anterior lower legs, and elbows. Also, hand- and toe-nail involvements were considerable. BMI, gender, smoking, PASI score, the duration of the disease, the time distance between diagnosis and treatment, and treatment regiments were found to affect the incidence of resistance to treatment in multiple areas, while age, the incidence of recalcitrant disease and/or psoriatic arthritis, and the duration of current treatment did not have effects. Conclusion. The most common refractory sites were the scalp, anterior lower legs, and elbows. This study should be followed up with larger samples containing a variety of biological treatments in order to evaluate the results.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/7399468","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138949977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma 治疗晚期皮肤 T 细胞淋巴瘤的莫干单抗多模式疗法与全身性类视黄醇、干扰素或体外射光疗法

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-12-19 DOI: 10.1155/2023/7625926

David M. Weiner, Supriya Rastogi, Daniel J. Lewis, Leah Cohen, Sara Choi, Carmela C. Vittorio, Paul L. Haun, Sara S. Samimi, Jennifer Villasenor-Park, Rahul S. Bhansali, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Ellen J. Kim, Alain H. Rook, Stefan K. Barta

{"title":"Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma","authors":"David M. Weiner, Supriya Rastogi, Daniel J. Lewis, Leah Cohen, Sara Choi, Carmela C. Vittorio, Paul L. Haun, Sara S. Samimi, Jennifer Villasenor-Park, Rahul S. Bhansali, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Ellen J. Kim, Alain H. Rook, Stefan K. Barta","doi":"10.1155/2023/7625926","DOIUrl":"10.1155/2023/7625926","url":null,"abstract":"<div>\u0000 Mogamulizumab is a novel monoclonal antibody designed to target CC chemokine receptor 4 (CCR4), which is expressed by tumor cells in cutaneous T-cell lymphoma (CTCL). In clinical trials, mogamulizumab monotherapy has demonstrated efficacy in reducing tumor burden in advanced CTCL, particularly in the peripheral blood. In clinical practice at our center, mogamulizumab has been combined with other agents such as systemic interferon, systemic retinoids, and extracorporeal photopheresis for an enhanced synergistic effect. There is limited published research on mogamulizumab combination therapy. This study evaluates the clinical efficacy of mogamulizumab in combination with systemic interferon, retinoids, and/or extracorporeal photopheresis for therapy of CTCL. Nineteen patients on this regimen at our academic center were identified. Treatment response rates, progression-free survival, duration of response, and adverse effects were characterized by retrospective chart review. All patients on this regimen at our center had an initial partial or complete response. Moreover, responses were durable, and the regimen was well-tolerated with few grade 3 adverse effects. These results demonstrate the utility of a multimodality approach to the therapy of CTCL with mogamulizumab and warrant further confirmation.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/7625926","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138959724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Gasdermin C (GSDMC) is Overexpressed in Psoriatic Tissue and Elevated in Psoriatic Serum: A Potential Marker of Cell Proliferation and Local Hypoxia in Psoriasis? Gasdermin C (GSDMC) 在银屑病组织中过度表达，并在银屑病血清中升高：银屑病细胞增殖和局部缺氧的潜在标记物？

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-12-16 DOI: 10.1155/2023/7813287

Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Anna Pryczynicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak

{"title":"Gasdermin C (GSDMC) is Overexpressed in Psoriatic Tissue and Elevated in Psoriatic Serum: A Potential Marker of Cell Proliferation and Local Hypoxia in Psoriasis?","authors":"Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Anna Pryczynicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak","doi":"10.1155/2023/7813287","DOIUrl":"10.1155/2023/7813287","url":null,"abstract":"<div>\u0000 Psoriasis is an important disease in dermatological practice and, despite many studies, its pathogenesis is still not fully understood. Gasdermin C (GSDMC; melanoma-derived leucine zipper-containing extranuclear factor, MLZE) is a member of the gasdermin protein family. The study enrolled 60 patients with active plaque-type psoriasis and 30 volunteers without dermatoses. GSDMC concentration was assessed in serum and urine samples of all participants using ELISA. GSDMC tissue expression was assessed by immunohistochemistry. The GSDMC concentration was significantly higher in serum of patients than in controls (p < 0.001). A urinary GSDMC/creatinine ratio was significantly lower in patients than in controls (p < 0.05). Psoriatic lesions exhibited a significantly higher expression of GSDMC than nonlesional patients’ skin or controls’ skin (p < 0.001, p < 0.01, respectively). There was a positive correlation between the GSDMC serum concentration and the age of patients (R = 0.31, p = 0.015) and a negative correlation between GSDMC and RBC (R = −0.37; p = 0.0038), HGB (R = −0.26; p = 0.047), and urea concentration (R = −0.36; p = 0.04). Our study shows the potential involvement of GSDMC in psoriasis. An increased serum GSDMC and a decreased urinary GSDMC/creatinine ratio could be considered noninvasive psoriasis biomarkers, especially of local hypoxia or cell proliferation.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/7813287","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138966860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unique Retinol Therapy with Antioxidant and Anti-Inflammaging Complex for Naturally Reborn Skin: The Clinical Case Series Study 独特的视黄醇疗法与抗氧化和抗炎复合物，让肌肤自然重生：临床案例系列研究

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-12-06 DOI: 10.1155/2023/5588525

D. Sołdacka, M. Podgórska, W. Barańska-Rybak

{"title":"Unique Retinol Therapy with Antioxidant and Anti-Inflammaging Complex for Naturally Reborn Skin: The Clinical Case Series Study","authors":"D. Sołdacka, M. Podgórska, W. Barańska-Rybak","doi":"10.1155/2023/5588525","DOIUrl":"10.1155/2023/5588525","url":null,"abstract":"<div>\u0000 One of the methods used to prevent symptoms of skin aging are chemical peels. Among retinoids, retinol is much less described in the literature than tretinoin as a substance used in the peel procedure. The aim of our study was to determine the efficacy of using a 4% retinol solution product containing novel TGF-β activators and antioxidants in improving the condition of the skin in patients with facial skin issues caused by aging and skin disorders. Each of 15 patients went through three peel treatment series, with a 30-day gap between each session and was examined using Multi Skin Test MC 1000 Courage + Khazaka, evaluating hydration, elasticity, and skin pigmentation and Observ 520x. All patients reported overall improvement after the peeling procedure, and most of them reported subjective improvement in the reduction of the facial skin: tone, skin pigmentation, dehydration, dryness, structure, and sebaceous gland activity. An objective evaluation revealed significant clinical improvement in pigmentation in study groups. Elasticity parameters were shown to increase during treatment, with a greater effect occurring in patients with mature skin with first signs of aging and patients with postinflammatory hyperpigmentation, atrophic acne scars, and enlarged pores. Concluding, combined peel therapy of 4% retinol serum product containing novel TGF-β activators and antioxidants showed good efficacy in reducing facial pigmentation of the skin high patients’ satisfaction with the procedure. The study revealed that the described method is simple to use, has low cost, is with rare adverse events, and has well tolerability.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/5588525","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138594180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of Cryotherapy and Topical Salicylic Acid in Common Warts: A Systematic Review and Meta-Analysis 冷冻疗法与外用水杨酸治疗寻常疣的比较：系统回顾与元分析

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-11-27 DOI: 10.1155/2023/4283918

Dipika Chaudhary, Yan Sun, Xinghua Gao

{"title":"Comparison of Cryotherapy and Topical Salicylic Acid in Common Warts: A Systematic Review and Meta-Analysis","authors":"Dipika Chaudhary, Yan Sun, Xinghua Gao","doi":"10.1155/2023/4283918","DOIUrl":"10.1155/2023/4283918","url":null,"abstract":"<div>\u0000 Background. Common warts are most common complaint among children and adults caused by human papillomavirus (HPV). Cryotherapy and topical salicylic acid are common therapies. Objective. To compare the efficacy and safety of cryotherapy and topical salicylic acid in common warts. Methods. Randomized controlled trials (RCTs) comparing cryotherapy and topical salicylic acid treatment in patients with common warts were searched by using PubMed, Embase, Google Scholar, and Cochrane Database of Systematic Reviews up to Oct 20, 2021. The keywords were “common warts/verruca,” “cryotherapy,” and “salicylic acid.” The language was restrained to English. No age or gender limitation was conducted. The outcomes were complete remission of all warts at different observation times, recurrence rates, and side effects. Study-specific effect sizes were pooled by using the fixed-effects model and the Mantel–Haenszel method. I2 was used to assess heterogeneity of studies. Results. Seven articles involving 976 patients randomized into the cryotherapy group or salicylic acid group were included. Of whom, 487 patients received cryotherapy, while 489 received salicylic acid treatment. With the fixed-effects model, the pool effect of complete clearance of warts at 12 weeks comparing cryotherapy and salicylic acid was not statistically significant (RR = 0.99 (0.84–1.17), I2 = 0%). Conclusion. Comparable efficacy of cryotherapy and topical salicylic acid was conducted in common wart treatment. More high-quality pieces of evidence with more samples are needed to confirm the results for further recommendations.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/4283918","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139232681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effectiveness of 730 nm Picosecond Laser for the Treatment of Freckles and Solar Lentigines: A Retrospective Analysis 730 nm 皮秒激光治疗雀斑和日光性色斑的效果：回顾性分析

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-11-23 DOI: 10.1155/2023/2070560

Qilei Che, Qingbiao Wa, Lufeng Liu, Qiuyue Tang, Yulian Gao, Jie Lu, Zixuan Zhou, Yuhong Xie

{"title":"Effectiveness of 730 nm Picosecond Laser for the Treatment of Freckles and Solar Lentigines: A Retrospective Analysis","authors":"Qilei Che, Qingbiao Wa, Lufeng Liu, Qiuyue Tang, Yulian Gao, Jie Lu, Zixuan Zhou, Yuhong Xie","doi":"10.1155/2023/2070560","DOIUrl":"10.1155/2023/2070560","url":null,"abstract":"<div>\u0000 Background. Freckles and solar lentigines are epidermal pigmentation disorders that affect the face and impact the quality of life of affected individuals. Aims. We aimed to observe and evaluate the clinical effectiveness of a 730 nm picosecond laser for the treatment of freckles and solar lentigines. Methods. We retrospectively collected patient information on freckles and solar lentigines and observed and evaluated the clinical outcome of a 730 nm picosecond laser. These included lesion clearance and recurrence rates, adverse reactions, and patient satisfaction. Results. Fifty cases of freckles and solar lentigines reported between January 1, 2022, and July 1, 2022, were included. All patients received two 730 nm picosecond laser treatments. The lesion clearance rates after one and two treatments were 53.1% and 78.4%, respectively, and the rates after one and six months of treatment were 78.7% and 78.4%, respectively. 90% of the patients reported ≥95% clearance of lesions after six months via a questionnaire survey. Among the patients, 86.0% were satisfied with their treatment. Postinflammatory hyperpigmentation occurred in two patients, both of whom had Fitzpatrick skin type IV. There was no recurrence of lesions. Conclusions. The 730 nm picosecond laser treatment for freckles and solar lentigines has the advantages of a high clearance rate, low recurrence rate, and high patient satisfaction. This trial is registered with ChiCTR2200058573.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/2070560","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139245631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mask-Acne Prevalence and Risk Factors during the COVID-19 Pandemic: A Cross-Sectional Single Institution Study COVID-19 大流行期间的口罩痤疮患病率和风险因素：单一机构横断面研究

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-11-21 DOI: 10.1155/2023/9470636

Ahmad Berjawi, Pascale Salameh, Naya Fadel, Jinane R. El Khoury

{"title":"Mask-Acne Prevalence and Risk Factors during the COVID-19 Pandemic: A Cross-Sectional Single Institution Study","authors":"Ahmad Berjawi, Pascale Salameh, Naya Fadel, Jinane R. El Khoury","doi":"10.1155/2023/9470636","DOIUrl":"10.1155/2023/9470636","url":null,"abstract":"<div>\u0000 Mask usage in healthcare workers became a requirement in all hospitals after the COVID-19 pandemic. Dermatologists have increasingly been diagnosing facial skin reactions that were attributed to or exacerbated by increased mask usage. “Mask-acne,” which is defined as a new onset or exacerbation of acne localized to the facial area under the mask, has been increasingly reported in the general population and healthcare workers during the COVID-19 pandemic. The purpose of this study is to assess the prevalence, severity, and risk factors contributing to mask-acne development among healthcare workers at a tertiary care center. The study was carried out via a web-based questionnaire. We evaluated healthcare workers’ demographics, mask behaviors, confounding factors, and prevalence of mask-acne. The total number of responders was 201, most responders were physicians (62.7%), and the surgical mask was the most used type of mask (62.1%). Results showed that 40.2% of healthcare workers developed mask-acne with 62.9% of them having new onset mask-acne and 37.1% having an exacerbation of preexisting acne. Age <30 years, female gender, and prolonged mask usage >8 hours were significantly associated with mask-acne development. The study highlights the prevalence of mask-acne among HCWs and risk factors that contribute to its development in the hospital setting.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/9470636","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139251445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Intradermal Local Injection of Autologous Cell-Free Fat Extract for the Treatment of Refractory Postinflammatory Hyperpigmentation 皮内局部注射自体无细胞脂肪提取物治疗难治性炎症后色素沉着症

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-11-17 DOI: 10.1155/2023/9561809

Yizuo Cai, Zhuoxuan Jia, Jiancheng Gu, Bijun Kang, Hongjie Zheng, Wei Li, Wenjie Zhang

{"title":"Intradermal Local Injection of Autologous Cell-Free Fat Extract for the Treatment of Refractory Postinflammatory Hyperpigmentation","authors":"Yizuo Cai, Zhuoxuan Jia, Jiancheng Gu, Bijun Kang, Hongjie Zheng, Wei Li, Wenjie Zhang","doi":"10.1155/2023/9561809","DOIUrl":"10.1155/2023/9561809","url":null,"abstract":"<div>\u0000 Current treatment modalities for postinflammatory hyperpigmentation (PIH) often fall short in delivering satisfactory results for some patients. Therefore, this study aimed to assess the efficacy and tolerability of autologous cell-free fat extract (CEFFE) in the treatment of PIH. We enrolled 15 patients with PIH and administered them with five intracutaneous CEFFE injections, each at a two-week interval. Evaluation included efficacy assessment using objective (standard two-dimensional photos, VISIA®-photos, brown spot (BS) index, lesion lightness, lesion color, and trans-epidermal water loss) and subjective (Global Aesthetic Improvement Scale and Likert satisfaction scale) parameters and tolerance assessment. Following CEFFE treatment, significant reductions were observed in the BS index (p < 0.05) and transepidermal water loss (p < 0.05), while skin lightness and lesion color showed significant improvements (p < 0.05) at the 12-month follow-up. Subjectively, 93.33% of patients reported improved or greatly improved conditions after 12 months of treatment. Transient local bruising and stinging were the only observed treatment-related adverse events, with no serious complications reported. These findings demonstrate that intradermal injections of CEFFE are well-tolerated and effective for the treatment of PIH. This trial is registered with ChiCTR2000039381.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/9561809","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139263942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Topical Scalp Serum Containing Adenosine, MgSO4, Vitamin CG, and Pre- and Probiotic Fractions Reduces Discomfort and Associated Symptoms of Sensitive Scalp 含有腺苷、MgSO4、维生素CG和益生菌前组分的局部头皮血清可减轻敏感头皮的不适和相关症状

IF 3.7 4区医学

Dermatologic Therapy Pub Date : 2023-11-13 DOI: 10.1155/2023/7225231

Philippe Massiot, Françoise Magne, Florence Weisgerber, Anais Thomet, Florence Pouradier, Geneviève Loussouarn, Delphine Kerob

{"title":"A Topical Scalp Serum Containing Adenosine, MgSO4, Vitamin CG, and Pre- and Probiotic Fractions Reduces Discomfort and Associated Symptoms of Sensitive Scalp","authors":"Philippe Massiot, Françoise Magne, Florence Weisgerber, Anais Thomet, Florence Pouradier, Geneviève Loussouarn, Delphine Kerob","doi":"10.1155/2023/7225231","DOIUrl":"10.1155/2023/7225231","url":null,"abstract":"<div>\u0000 Purpose. Sensitive scalp (SScalp) is characterized by abnormal and nociceptive sensations, such as stinging and itching, that lead to scalp discomfort. This study assessed the benefit of a once-daily serum containing Adenosine, Magnesium Sulfate (MgSO4), Vitamin C Glucoside (CG), and pre- and probiotic fractions in subjects with SScalp. Methods. An open-label, single center study in adult subjects with a Global Scalp Discomfort (GSD) score of ≥8 (0–27), defined as the sum of individual symptom scores (0–9) for itching, stinging, and warming sensations. The frequency of scratching was self-declared. Evaluations were performed immediately after the 1st application (D0Timm) and at D21, during which the cosmetic acceptability was additionally assessed. Transepidermal water loss and skin hydration were assessed at baseline, D21, and D28. Squalene (SQ) and SQOOH were analyzed at D0T0, D21T0, and D28. Tolerance was assessed throughout the study. Results. 42 subjects (30 women and 12 men) participated in this study. The mean age was 44.0 ± 13.0 years. At baseline, the mean GSD was 13.9 ± 3.28. The GSD and symptoms significantly (p < 0.0001) improved at D0Timm and lasted until the end of the study (D28), with insignificant worsening. There was a significant reduction of SQOOH at D21 and D28. Subject satisfaction was high, associated with a good tolerance. A similar and significant (p < 0.0001) improvement was observed for subjects with more severe symptoms and a GSD score ≥14 at baseline. Conclusion. The topical serum significantly reduces SScalp, global discomfort, and oxidative stress and is beneficial in the management of sensitive scalp. This TRIAL is registered with NCT05630027.\u0000 </div>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2023 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/7225231","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136351629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0